Feature Type | Standardized |
Nominal ANOVA |
||||
---|---|---|---|---|---|---|
mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.08 |
mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.08 |
mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.2 | 0.08 |
mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.079 | 0.08 |
mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.08 |
mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.08 |
mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.33 | 0.08 |
mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |